Dynavax Technologies Corporation
2 products found
Dynavax Technologies Corporation products
Hepatitis B Vaccine (Recombinant) Adjuvanted
HEPLISAV-B is indicated for prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.1
Cutting-Edge Vaccines
We believe the immune system is a valuable and critical tool that can be harnessed to prevent and treat disease. We are developing cutting-edge vaccines based on Toll-like Receptor (TLR) biology and its ability to control and modulate the immune system.